This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Dermatology
  • /
  • Ustekinumab in adolescent patients age 12 to 17 ye...
Journal

Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study.

Read time: 1 mins
Published:1st Oct 2015
Author: Landells I, Marano C, Hsu MC, Li S, Zhu Y, Eichenfield LF, et al.
Availability: Free full text
Ref.:J Am Acad Dermatol. 2015 Oct;73(4):594-603.
DOI:10.1016/j.jaad.2015.07.002.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest